Product Images Dextrose

This text provides important prescribing information from Baxter Healthcare Corporation regarding the temporary importation of Sterile Water for Injection and 70% Dextrose Injection from Canada to address drug shortages in the United States. The products being imported are USP 1,000 mL Pharmacy Bulk Package of Sterile Water for Injection and USP 3,000 mL Pharmacy Bulk Package of 70% Dextrose Injection from Baxter's manufacturing facility in Alliston, Canada. It is mentioned that FDA has not approved these products manufactured by Baxter’s Alliston facility, emphasizing the need for temporary importation to prevent drug shortages. Healthcare professionals are instructed to read additional letters for product-specific information on imported products. Baxter is the only entity authorized by FDA for import and distribution of these products in the United States during this temporary period.*

This text provides information on bags per NDC code, including product names, sizes, and product codes for Sterile Water for Injection and 70% Dextrose Injection. It emphasizes the importance of visually inspecting bags for particulate matter or defects before administration to ensure sterility. It also recommends using a new bag if particulates are visible or if there is a leak. Additionally, it states that the imported products are not for direct patient use and advises checking compatibility and stability when compounding with them.*

This text provides important information regarding the compatibility of imported medical products with Baxter sets in the United States, differences in barcode systems, and labeling variations between FDA-approved products and imported ones. It mentions the need for manual input of product information for accurate tracking, as well as the availability of certain prescription products without the "Rx only" statement on imported labels. Further details are given in product comparison tables at the end of the text.*

This text provides information on how to report adverse events or product quality issues related to imported products. It includes contact details for Baxter, the FDA's MedWatch Adverse Event Reporting program, and guidance on submitting reports online, by regular mail, or fax. Additionally, it directs individuals on how to report product quality issues through Baxter Product Surveillance. It also suggests referring to the FDA-approved prescribing information for each drug product, specifically mentioning Sterile Water for Injection USP.*

This is a notification providing contact information for purchasing and inquiries regarding 70% Dextrose Injection USP by Baxter Healthcare Corporation. For questions about the product or imported items, contact Baxter's Medical Information Service at 1-800-933-0303. To place an order, reach out to Baxter's Center for Service at 1-888-229-0001. The signatory is Lee Ann Schuette, the Vice President of Global and US Marketing IV solutions, Clinical Nutrition, and Pharmacy Tools at Baxter Healthcare Corporation. Baxter and Viaflex are trademarks of Baxter International Inc.*

This text provides a comparison table between FDA-approved and imported Sterile Water for Injection USP. It includes key differences such as product name, label volume, language(s) on the label, active ingredients, and additional information like osmolarity. The table compares volume sizes, languages used, as well as the purpose of Sterile Water for Injection in aseptic preparations of parenteral admixtures. Active ingredients and osmolarity values are also compared between the FDA-approved product and the imported product from Canada.*

This text provides information on how to store a medication in a container called VIAFLEX (PVC) VIARLEXPVE. It suggests storing the medication at room temperature between 15°C/55°F and 25°C/77°F and emphasizes protecting it from freezing. The container includes an administration port and recommends removing the blue-colored port protector before use.*

This text provides detailed information about FDA-approved and imported Sterile Water for Injection USP. It includes descriptions of the product labels, warnings, dosage instructions, and storage recommendations. The text emphasizes the importance of maintaining sterility, proper handling procedures, and using aseptic techniques when compounding admixtures. Additionally, it specifies the expiration time frame and cautions against using the solution if it is not clear or if the seal is broken. Overall, this text serves as a comprehensive guide for healthcare professionals on the proper use and storage of Sterile Water for Injection USP.*

This text describes key differences between FDA-approved and imported 70% Dextrose Injection USP. The FDA-approved product contains 70% Dextrose Injection USP with a label volume of 2,000 mL, while the imported product from Canada also contains 70% Dextrose Injection USP but with a label volume of 3,000 mL. The text details the indications for use, active ingredients, and total content of active ingredient in each product.*

This appears to be a detailed description of two different 70% Dextrose USP products, one being FDA-approved and the other being imported from Canada. The products come in Pharmacy Bulk Packages and include instructions for proper use and storage. Both products have different label colors and details related to their composition, dosage, and administration. The description mentions cautions about clear solutions, intact closures, and detecting leaks. Specific instructions are provided for diluting the products before infusion and discarding unused contents within a specific timeframe. The text also highlights the normal color variation of the solution and advises on storage temperature to maintain its efficacy. Additionally, the description includes information about the VIAFLEX containers, as well as trademarks and contact information for Baxter International Inc.*

This content is information about a 3000 mL bag of 70% Dextrose Injection USP. It is intended for intravenous fluid and nutrient replenishment and should be diluted before infusion. The bag contains no more than 25 g/L of aluminum and is suitable for injection. The recommended shelf storage temperature is between 15°C to 25°C. The bag should be squeezed and inspected before use. Unused contents should be discarded within 4 hours of initial entry. Prescription information is available upon request. The product comes in a Viaflex PVC container and is a trademark of Baxter International Inc.*

This is a label for a medical product indicating that it is 70% Dextrose Injection USP to be stored at temperatures ranging from 15°C to 25°C. The lot number of the product is followed by an expiration date of 2099.*